MATINAS BIOPHARMA HLDGS INC's ticker is MTNB and the CUSIP is 576810105. A total of 48 filers reported holding MATINAS BIOPHARMA HLDGS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,560 | -66.7% | 12,000 | -7.7% | 0.00% | – |
| Q2 2023 | $4,680 | -29.9% | 13,000 | -8.5% | 0.00% | – |
| Q1 2023 | $6,674 | -60.7% | 14,200 | -54.5% | 0.00% | – |
| Q4 2022 | $17,000 | -19.0% | 31,200 | 0.0% | 0.00% | – |
| Q3 2022 | $21,000 | -12.5% | 31,200 | 0.0% | 0.00% | – |
| Q2 2022 | $24,000 | -4.0% | 31,200 | 0.0% | 0.00% | – |
| Q1 2022 | $25,000 | -19.4% | 31,200 | 0.0% | 0.00% | – |
| Q4 2021 | $31,000 | -8.8% | 31,200 | +19.1% | 0.00% | – |
| Q3 2021 | $34,000 | +100.0% | 26,200 | +18.0% | 0.00% | – |
| Q2 2021 | $17,000 | -26.1% | 22,200 | 0.0% | 0.00% | – |
| Q1 2021 | $23,000 | -14.8% | 22,200 | +11.0% | 0.00% | – |
| Q4 2020 | $27,000 | +80.0% | 20,000 | 0.0% | 0.00% | – |
| Q3 2020 | $15,000 | +200.0% | 20,000 | +233.3% | 0.00% | – |
| Q2 2020 | $5,000 | +25.0% | 6,000 | 0.0% | 0.00% | – |
| Q1 2020 | $4,000 | – | 6,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 1,429,532 | $1,944,000 | 0.61% |
| Boxer Capital, LLC | 11,478,634 | $15,611,000 | 0.50% |
| Vivo Capital, LLC | 6,451,612 | $8,774,000 | 0.39% |
| Philadelphia Financial Management of San Francisco, LLC | 740,861 | $1,008,000 | 0.26% |
| DCF Advisers, LLC | 305,299 | $415,000 | 0.17% |
| Main Street Financial Solutions, LLC | 400,826 | $545,000 | 0.11% |
| Platform Technology Partners | 158,660 | $216,000 | 0.10% |
| STALEY CAPITAL ADVISERS INC | 600,000 | $816,000 | 0.05% |
| MONECO Advisors, LLC | 50,000 | $81,000 | 0.04% |
| CCG WEALTH MANAGEMENT, LLC | 30,000 | $41,000 | 0.04% |